
US retail giant Walmart will soon be selling its own brand of analog insulin, which will be produced by Novo Nordisk, according to Bloomberg News.
The insulin analog known as Relion Novolog will be between 58 and 75 percent cheaper than other brands for patients with no insurance, Walmart states in a press release.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app